# Study: Cannabis-Based Treatments Linked to Long-Term Improvements in Migraine > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-migraine-treatment-outcomes-long-term-benefits/ > **Published:** 2026-04-07T14:03:02-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:28:15-04:00 > **Clinical Summary:** Explore cannabis migraine treatment outcomes showing long-term improvements in symptom severity and quality of life for chronic migraine sufferers. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Migraine[Chronic Pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/)NeurologyThcQuality Of Life Why This Matters Migraine affects over 1 billion people globally and remains undertreated, with many patients experiencing inadequate relief from conventional therapies. This study adds to growing evidence that cannabis may offer a viable treatment option for chronic migraine sufferers who have failed standard prophylactic and abortive medications. Clinical Summary The study examined long-term outcomes in migraine patients using [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/), reporting sustained improvements in both symptom severity and quality of life measures. While the specific cannabinoid profiles, dosing protocols, and patient selection criteria require careful evaluation, the findings suggest potential therapeutic benefit beyond acute symptom relief. The mechanism likely involves modulation of the endocannabinoid system’s role in pain processing and neuroinflammation, though the precise pathways remain under investigation. Dr. Caplan’s Take “I’m encouraged by data showing sustained benefit rather than just acute relief, but we need to see the methodology before drawing clinical conclusions. The real question is whether these improvements persist when we account for placebo effects and patient selection bias in what was likely an observational study.” Clinical Perspective 🧠 Clinicians should view this as preliminary evidence supporting cannabis as adjunctive therapy for refractory migraine cases, not first-line treatment. For patients considering this approach, emphasis should remain on strain selection, consistent dosing, and careful monitoring of both therapeutic response and potential adverse effects including medication overuse headache patterns. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Study%3A%20Cannabis-Based%20Treatments%20Linked%20to%20Long-Term%20Improvements%20in%20Migraine%20.....%20%40drcaplan&url=https%3A//themarijuanaherald.com/2026/04/study-cannabis-based-treatments-linked-to-long-term-improvements-in-migraine-symptoms-and-quality-of-life/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//themarijuanaherald.com/2026/04/study-cannabis-based-treatments-linked-to-long-term-improvements-in-migraine-symptoms-and-quality-of-life/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Study%3A%20Cannabis-Based%20Treatments%20Linked%20to%20Long-Term%20Improvements%20in%20Migraine%20.....%20--%20via%20%40drcaplan.bsky.social%20https%3A//themarijuanaherald.com/2026/04/study-cannabis-based-treatments-linked-to-long-term-improvements-in-migraine-symptoms-and-quality-of-life/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://themarijuanaherald.com/2026/04/study-cannabis-based-treatments-linked-to-long-term-improvements-in-migraine-symptoms-and-quality-of-life/](https://themarijuanaherald.com/2026/04/study-cannabis-based-treatments-linked-to-long-term-improvements-in-migraine-symptoms-and-quality-of-life/) Table of Contents - [FAQ](#FAQ)[What conditions does this cannabis research focus on?](#What_conditions_does_this_cannabis_research_focus_on) - [What is the clinical relevance rating of this study?](#What_is_the_clinical_relevance_rating_of_this_study) - [What cannabis component is being studied?](#What_cannabis_component_is_being_studied) - [Is this research new or recently published?](#Is_this_research_new_or_recently_published) - [What type of medical practice would find this research most relevant?](#What_type_of_medical_practice_would_find_this_research_most_relevant) - [Related](#Related) ## FAQ #### What conditions does this cannabis research focus on? This research primarily examines [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) for migraine and [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) conditions. The study falls under neurology specialty care and has high clinical relevance for pain management. #### What is the clinical relevance rating of this study? This study has received a “High Clinical Relevance” rating (#80) from CED. This indicates strong evidence or policy relevance with direct implications for clinical practice. #### What cannabis component is being studied? The research focuses on THC (tetrahydrocannabinol), which is the primary psychoactive compound in cannabis. THC is commonly studied for its potential therapeutic effects on pain and neurological conditions. #### Is this research new or recently published? Yes, this article is marked as “New” content from CED Clinical. This suggests the research findings or clinical implications are recently published or updated. #### What type of medical practice would find this research most relevant? This research would be most relevant to neurology practices, pain management clinics, and healthcare providers treating chronic pain conditions. The high clinical relevance rating suggests it has direct applications for [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Medical Cannabis Can Provide Sustained Relief for Migraines – NORML](https://cedclinic.com/longitudinal-study-medical-cannabis-migraine-relief/) This article discusses how [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) offers sustained relief for migraine sufferers, highlighting clinical evidence and patient experiences. [Read More](https://cedclinic.com/longitudinal-study-medical-cannabis-migraine-relief/) [New Study Suggests Cannabinoids May Offer Relief for Chronic Pain Conditions Including …](https://cedclinic.com/new-study-suggests-cannabinoids-may-offer-relief-for-chronic-pain-conditions-including/) Explore recent research on cannabinoids providing relief for various chronic pain conditions, including migraine and neuropathic pain. [Discover Insights](https://cedclinic.com/new-study-suggests-cannabinoids-may-offer-relief-for-chronic-pain-conditions-including/) [Some Cannabinoids May Ease Common Chronic Pain Conditions, Study Finds](https://cedclinic.com/some-cannabinoids-may-ease-common-chronic-pain-conditions-study-finds/) This study reviews the potential of cannabinoids to ease symptoms in chronic pain conditions, supporting their therapeutic role. [Learn More](https://cedclinic.com/some-cannabinoids-may-ease-common-chronic-pain-conditions-study-finds/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).